α1-Antitrypsin in Fibromyalgia: Results of a Randomized, Placebo-Controlled, Double-Blind and Crossover Pilot Trial
✍ Scribed by Cayetano Alegre; Mireia Barceló; Rosendo Jardí; Francisco Rodríguez-Frias; Sandra Camprubí
- Book ID
- 112147576
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 609 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1478-2189
- DOI
- 10.1002/msc.1000
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin
## Abstract McArdle's disease causes limitation in exercise capacity as well as disability, the severity of which has been associated with the angiotensin‐converting enzyme (ACE) insertion (I)/deletion (D) haplotype—patients with the genotype associated with higher ACE activity show the most severe